C. Blasco

443 total citations
9 papers, 222 citations indexed

About

C. Blasco is a scholar working on Oncology, Genetics and Biotechnology. According to data from OpenAlex, C. Blasco has authored 9 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Genetics and 4 papers in Biotechnology. Recurrent topics in C. Blasco's work include Virus-based gene therapy research (4 papers), Cancer Research and Treatments (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). C. Blasco is often cited by papers focused on Virus-based gene therapy research (4 papers), Cancer Research and Treatments (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). C. Blasco collaborates with scholars based in Spain and United States. C. Blasco's co-authors include José C. Fernández‐Checa, Anna Colell, Montserrat Marı́, Josep M. Lluis, Carmen García‐Ruiz, Albert Morales, Albert Parés, Juan José Mora Román, Joan Rodés and Joan Caballería and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Hepatology.

In The Last Decade

C. Blasco

8 papers receiving 220 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Blasco Spain 4 101 50 49 42 40 9 222
Yolanda Chico Spain 12 152 1.5× 79 1.6× 45 0.9× 36 0.9× 71 1.8× 24 332
Guowen Yin China 11 96 1.0× 59 1.2× 61 1.2× 9 0.2× 77 1.9× 25 348
Cheng Fang China 10 259 2.6× 45 0.9× 60 1.2× 23 0.5× 29 0.7× 22 408
Jianhua Cai China 11 185 1.8× 48 1.0× 72 1.5× 17 0.4× 17 0.4× 24 343
Sumin Sun China 6 126 1.2× 23 0.5× 20 0.4× 13 0.3× 107 2.7× 11 283
Yiming Fu China 11 138 1.4× 14 0.3× 65 1.3× 13 0.3× 66 1.6× 34 338
Bridgett Knox United States 10 179 1.8× 18 0.4× 56 1.1× 19 0.5× 30 0.8× 14 276
Astrid Jullumstrø Feuerherm Norway 10 102 1.0× 12 0.2× 37 0.8× 18 0.4× 16 0.4× 21 270
Amin Esmaeilniakooshkghazi United States 7 207 2.0× 11 0.2× 33 0.7× 23 0.5× 31 0.8× 9 285

Countries citing papers authored by C. Blasco

Since Specialization
Citations

This map shows the geographic impact of C. Blasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Blasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Blasco more than expected).

Fields of papers citing papers by C. Blasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Blasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Blasco. The network helps show where C. Blasco may publish in the future.

Co-authorship network of co-authors of C. Blasco

This figure shows the co-authorship network connecting the top 25 collaborators of C. Blasco. A scholar is included among the top collaborators of C. Blasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Blasco. C. Blasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
García‐Carbonero, Rocio, Roberto Pazo-Cid, Teresa Macarulla, et al.. (2024). VIRAGE: A phase IIb, open-label, randomized study of nab-paclitaxel and gemcitabine plus/minus VCN-01 in patients with metastatic pancreatic cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS4210–TPS4210. 1 indexed citations
3.
4.
Jové, Maria, Irene Braña, Miren Taberna, et al.. (2019). 128TiP VCN-01 plus durvalumab in subjects with recurrent/metastatic head & neck squamous cell carcinoma (R/M HNSCC): Phase I clinical trial. Annals of Oncology. 30. xi47–xi47. 1 indexed citations
5.
García‐Carbonero, Rocio, Marta Gil-Martín, T. Macarulla Mercadé, et al.. (2019). Systemic administration of the hyaluronidase-expressing oncolytic adenovirus VCN-01 in patients with advanced or metastatic pancreatic cancer: First-in-human clinical trial. Annals of Oncology. 30. v271–v272. 9 indexed citations
6.
Hidalgo, Manuel, Miriam Bazán‐Peregrino, Berta Laquente, et al.. (2019). Proof of concept clinical study by US-guided intratumor injection of VCN-01, an oncolytic adenovirus expressing hyaluronidase in patients with pancreatic cancer. Annals of Oncology. 30. v171–v172. 2 indexed citations
7.
Gil‐Gil, Miguel, Meritxell Bellet, Serafín Morales, et al.. (2015). Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study. Breast Cancer Research and Treatment. 151(3). 597–606. 39 indexed citations
8.
Lluis, Josep M., Albert Morales, C. Blasco, et al.. (2004). Critical Role of Mitochondrial Glutathione in the Survival of Hepatocytes during Hypoxia. Journal of Biological Chemistry. 280(5). 3224–3232. 89 indexed citations
9.
Román, Juan José Mora, Anna Colell, C. Blasco, et al.. (1999). Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: Effect on transcription factors AP-1 and NF-κB. Hepatology. 30(6). 1473–1480. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yolanda Chico Breakdown of academic impact, for papers by Guowen Yin Breakdown of academic impact, for papers by Cheng Fang Breakdown of academic impact, for papers by Jianhua Cai Breakdown of academic impact, for papers by Sumin Sun Breakdown of academic impact, for papers by Yiming Fu Breakdown of academic impact, for papers by Bridgett Knox Breakdown of academic impact, for papers by Astrid Jullumstrø Feuerherm Breakdown of academic impact, for papers by Amin Esmaeilniakooshkghazi
Rankless by CCL
2026